Q2 2010

Filed Nov 15, 2010 · 10-Q · 46 days after period end · 0001393905-10-000675

Q2 2010 · 10-Q

Revenue

$399.58K

no prior Q2 2009 on file

Net Income

-$1.57M

no prior Q2 2009 on file

EPS Diluted

-$0.30

no prior Q2 2009 on file

Operating Income-$862,058—

Operating Cash Flow

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 15, 2010 · 46 d after period end

Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR